Teva
Mega deal: Teva acquires Emalex for approximately $900 million
The Israeli pharmaceutical giant is accelerating its growth strategy and adding to its portfolio a groundbreaking treatment for Tourette syndrome in children.
IATI CEOs Forum meets in Kiryat Gat to discuss multinational industry resilience
Teva honored for gender equality as women reach 43% of senior management in Israel
Teva collaborates on skin disease treatment, releases targets
US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute
Israel's Teva Pharmaceuticals and GlaxoSmithKline (GSK) have been disputing over this patent lawsuit since 2014.
Israeli drugmaker Teva says opioids settlement to move forward in US
As a result of the opiod crisis, more than 932,000 people have died in the US since 1999 from a drug overdose.
US Parkinson's disease incidence far higher than earlier estimates -study
Analysis of insurance claims and population growth indicates higher numbers than previously thought - and they will continue to rise.
NYSE gala honors Pfizer, Teva Pharmaceuticals, Silverstein Properties, Azrieli Group
Israel Day, organized and hosted by the America-Israel Friendship League and Israeli Mapped in NY annually holds the event in collaboration with the NY Stock Exchange to honor Israeli tech
Teva to pay $523m. to New York as it looks to move past opioid lawsuits
Teva Pharmaceutical Industries will pay up to $523 million to New York State as part of a nationwide settlement of lawsuits alleging the company helped fuel the US opioid epidemic.
Israel's Teva pharmaceuticals company keeps selling to Russia despite sanctions
Teva CEO Kare Schultz said that despite sanctions, Teva still sells medications to Russia, because this is a humanitarian move. He also revealed that Teva donates medicines to Ukraine.
Israel's Teva Pharm to start paying US opioid settlement in 2023, says CEO
The US opioid crisis has caused more than 500,000 overdose deaths over the past two decades, including more than 80,000 in 2021 alone.
CVS, Walmart, Walgreens ordered to pay $650.6m. in Ohio in opioid case
The litigation has resulted in several nationwide settlements, including a $4.25 billion settlement with Israel-based Teva Pharmaceutical Industries
AION, aMoon up for top scientific innovation award
AION Labs brings together some of the biggest names in pharma, including AstraZeneca, Merck and Pfizer, and aMoon is Israel’s largest health-tech fund.
Israeli Teva reaches proposed $4.35 bln settlement of US opioid lawsuits
The US opioid crisis has caused more than 500,000 overdose deaths over the past two decades, including more than 80,000 in 2021 alone.